{"disease":{"id":"leiomyomatosis","name":"leiomyomatosis"},"drugs":{"marketed":[{"drug_id":"rapamune","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamune","company_name":"Wyeth is now a wholly owned subsidiary of Pfizer","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"sirolimus","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rapamune","generic_name":"sirolimus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase mTOR","drug_class":"mTOR Inhibitor Immunosuppressant [EPC]","quality_score":80,"revenue":null,"mechanism":"Rapamune works by binding to the mTOR protein, inhibiting its activity and preventing the growth and proliferation of certain cells."},{"drug_id":"rapamycin","indication_name":"Pulmonary lymphangioleiomyomatosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rapamycin","company_name":"Institut National de la Santé Et de la Recherche Médicale, France","drug_phase":"marketed","molecular_target":"Peptidyl-prolyl cis-trans isomerase FKBP3, Sodium/nucleoside cotransporter 1, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00001465","title":"Study of the Disease Process of Lymphangioleiomyomatosis","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04623502","title":"An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT06160310","title":"Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"David M. Ritter","has_results":false},{"nct_id":"NCT00366509","title":"Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT01552434","title":"Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":155,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06405997","title":"The Genotype and Phenotype of Lymphangioleiomyomatosis","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT01799538","title":"Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07304856","title":"Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT04981509","title":"Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":65,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05190627","title":"Effect of Loratadine in Lymphangioleiomyomatosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"Institut d'Investigació Biomèdica de Bellvitge","has_results":false},{"nct_id":"NCT03150914","title":"Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Cincinnati","has_results":false},{"nct_id":"NCT04184193","title":"Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)","phase":"","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Schön Klinik Berchtesgadener Land","has_results":false},{"nct_id":"NCT00552955","title":"Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03304678","title":"Discovery of Sirolimus Sensitive Biomarkers in Blood","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT06773819","title":"A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03253913","title":"Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of Cincinnati","has_results":true},{"nct_id":"NCT02654340","title":"Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)","phase":"","overall_status":"TERMINATED","enrollment_count":20,"lead_sponsor_name":"CENTOGENE GmbH Rostock","has_results":false},{"nct_id":"NCT05323370","title":"Lymphangioleiomyomatosis, a Study on Cathepsin K","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT00971620","title":"Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03131999","title":"LAM Pilot Study With Imatinib Mesylate","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Medical University of South Carolina","has_results":true},{"nct_id":"NCT04577937","title":"Sleep Patterns in Patients Affected by Lymphangioleiomiomatosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"dr. Stefano Nava","has_results":false},{"nct_id":"NCT02484664","title":"COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT02859194","title":"The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT02495103","title":"Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05467397","title":"Feasibility of [11C]Acetate-PET in LAM and TSC","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT04388371","title":"Glutamine PET Imaging in LAM","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04603365","title":"Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}